Matoke® Pharma Covered In The Telegraph On Antibiotic Research

The Telegraph, ‘As superbugs threaten to create a global crisis, why are pharmaceutical companies shying away from antibiotics research?’, 14th April 2019

Alan Westwood, Matoke® Pharma’s Managing Director, is featured in The Telegraph discussing the challenges of antibiotic research and the need for new treatments to combat the rise of global superbugs.

Matoke® Pharma is working to develop novel antimicrobial products that can help overcome the threat of resistance based on Reactive Oxygen® technology, which has the potential for biofilm penetration, tissue regeneration, wound healing and immune system stimulation.

To read the article, click here.

Leave a Reply

Your email address will not be published. Required fields are marked *